MeCP2 Gene Therapy Ameliorates Disease Phenotype in Mouse Model for Pitt Hopkins Syndrome

Researchers discovered that MeCP2 levels were decreased in PTHS patient iNPCs relative to healthy controls and that both iNPCs and iAstrocytes displayed defects in function and differentiation in a mutation-specific manner.